Deliver to 
0 review
1 of 5
60cb5409-045a-445a-bb3a-6f1fa9c296cf.jpeg
2 of 5
e46e9d3f-1bd1-46d5-8e74-dd710d9416a6.png
3 of 5
d9eff350-26bb-4509-994e-a6f0f9e66d9d.jpeg
4 of 5
3c882230-b606-4a26-a35a-b2aa8e6f542f.jpeg
5 of 5
шшшшт.jpeg
60cb5409-045a-445a-bb3a-6f1fa9c296cf.jpeg
e46e9d3f-1bd1-46d5-8e74-dd710d9416a6.png
d9eff350-26bb-4509-994e-a6f0f9e66d9d.jpeg
3c882230-b606-4a26-a35a-b2aa8e6f542f.jpeg
шшшшт.jpeg

EKDISTEN Metabolic agent

byone
437 sales
$109.00 
(was $144.00)
 & FREE Shipping
You Save:$35.00
24% off

Quantity

plus icon1plus icon
About this item
down arrow
  • Ekdisten in terms of 100% substance- 0.005 gExcipientsSugar (sucrose)- 0.089 gpotato starch- 0.005 gcalcium stearate- 0.001 gTablet weight- 0.1 g
Item description from the seller
down arrow
EKDISTEN Metabolic agent
 
IT IS USED IN SPORTS MEDICINE FOR MENTAL AND PHYSICAL OVERFATIGUE IN ATHLETES DURING PREPARATION FOR COMPETITIONS
Registration number: LP-001600
Trade name of the drug: Ekdisten
Chemical name: 2b, 3b, 14a, 20R, 22R, 25-Hexahydroxy-5b-cholesten-7-OH-6
Composition per tablet
active ingredient
Ekdisten in terms of 100% substance
- 0.005 g
Excipients
Sugar (sucrose)
- 0.089 g
potato starch
- 0.005 g
calcium stearate
- 0.001 g
Tablet weight
- 0.1 g
Description
Tablets are round, flat-cylindrical, with a bevel, from white to white with a yellowish tint.
Pharmacotherapeutic group
metabolic agent.
Pharmacological properties
Natural compound of the steroid structure from the roots and rhizomes of leuzea safflower; has a tonic effect, enhances the processes of protein synthesis in the body. Increases mental and physical performance.
Indications for use
Asthenic syndrome associated with the weakening of protein-synthesizing processes; with prolonged intoxication, infections; mental and physical overwork; in athletes, as a drug that increases speed-strength qualities in preparation for competitions.
Contraindications
Increased individual sensitivity to the components of the drug, nervous agitation, insomnia, arterial hypertension, epilepsy, hyperkinesis, peptic ulcer of the stomach and duodenum (in the acute stage), congenital fructose intolerance, glucose-galactose malabsorption, sucrase / isomaltase deficiency, pregnancy and breastfeeding , age up to 18 years.
If you have one of the listed diseases, be sure to consult your doctor before taking the drug.
Carefully
Patients with diabetes and those on a low carbohydrate diet.
Dosage and administration
Inside, 0.005-0.01 g (1-2 tablets) 3 times a day after meals; course of treatment - 15-20 days; on the recommendation of a doctor, it is possible to conduct a second course of treatment in 1-2 weeks; in sports medicine, 0.01 g (2 tablets) is used 3 times a day for 2-3 weeks; the maximum single dose is 0.01 g (2 tablets), the highest daily dose is 0.03 g (6 tablets).
Side effect
Possible insomnia, increased blood pressure, pain in the epigastric region.
If any of the side effects listed in the instructions get worse, or if you notice any other side effects not listed in the instructions, tell your doctor.
Overdose
In case of overdose, dose-dependent adverse reactions may increase. Treatment: symptomatic.
Interaction with other drugs
With simultaneous use, it is possible to enhance the action of stimulants and analeptics (caffeine, camphor, phenamine); the drug is an antagonist of drugs that depress the central nervous system (including neuroleptics, barbiturates, tranquilizers, anticonvulsants).
special instructions
To achieve the effect, simultaneously with the use of the drug, it is necessary to receive adequate amounts of proteins, fats, carbohydrates, vitamins and minerals with food.
In the event of side effects, including in order to avoid sleep disturbance, it is advisable to reduce the dose or stop taking the drug in the evening.
Patients with diabetes should take into account that one tablet of the drug contains about 0.094 g of carbohydrates (0.008 XE).
The use of the drug does not affect the ability to drive vehicles and engage in other potentially hazardous activities that require increased concentration and speed of psychomotor reactions.
Release form
Tablets 5 mg. 10 tablets in a blister pack. 3 or 5 blister packs together with instructions for use in a cardboard pack.
Storage conditions
In a dry, dark place at a temperature not exceeding 25°C.
Keep out of the reach of children.
Best before date
2 years. Do not use after the expiration date.